-
Published 8/3/2026
Steinberg MH. Subphenotypes of Sickle Cell Disease: A Guide to Targeting Treatment? Am J Hematol. 2026 Aug 03. PMID: 42545170.
-
Published 6/23/2026
Benmhammed H, Sun Y, AlAbdullatif S, Chen A, Khan S, Zadeh AM, Mazile N, Beacham GM, Mahdaviani K, Williams C, Alekseyev YO, Campbell JD, Hagedorn EJ, Heaphy C, Klings ES, Steinberg MH, Cui S. PGC-1a agonism via oral administration of ZLN005 induces fetal hemoglobin and is antisickling in sickle mice. Blood Adv. 2026 Jun 23; 10(12):4358-4369. PMID: 42024469.
-
Published 6/11/2026
Frangoul H, de la Fuente J, Chopra Y, Meisel R, Amrolia PJ, Algeri M, Sharma A, Cappellini MD, Corbacioglu S, Kattamis A, Lobitz S, de Montalembert M, Rondelli D, Sheth S, Steinberg MH, Walters MC, Boerner K, Liu T, Zairis S, Hobbs W, Grupp SA, Locatelli F. Exa-cel in Children with Transfusion-Dependent ß-Thalassemia or Sickle Cell Disease. N Engl J Med. 2026 Sep 10; 395(10):947-958. PMID: 42274009.
-
Published 6/4/2026
Lofters J, Wilks A, Lee J, Hicks JN, Klings ES, Steinberg MH. HbF/F-cell and the Phenotype of Sickle Cell Disease. medRxiv. 2026 Jun 04. PMID: 42282210.
-
Published 5/21/2026
Pate B, Goldstein A, Labott M, Lizarralde-Iragorri M, Chankhunthod A, Tyson T, Sloan M, Wijeyesekera C, Wilks A, Steinberg MH, Murphy GJ, Vanuytsel K. Modeling Genetic Diversity in Sickle Cell Disease Reveals Heterogeneous Responses to HbF-Inducing Therapies. bioRxiv. 2026 May 21. PMID: 42239194.